NCT07101965

Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To evaluate the safety and tolerability of RSS0343 tablets in healthy subjects after single and multiple oral administration

Conditions

• Health Volunteer

Interventions

Type	Name	Description
DRUG	RSS0343 tablets ；placebo	RSS0343 tablets and placebo were given orally as a single dose
DRUG	RSS0343 tablets ；placebo	RSS0343 tablets and placebo were taken orally multiple times

Timeline

• Start date: 2024-04-07
• Primary completion: 2024-11-06
• Completion: 2024-11-06
• First posted: 2025-08-03
• Last updated: 2025-08-03

Locations

1 site across 1 country: China